{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:51:54Z","timestamp":1781643114975,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_215461"],"award-info":[{"award-number":["310030_215461"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Fribourg's research pool","award":["2021-19 and 2020-20"],"award-info":[{"award-number":["2021-19 and 2020-20"]}]},{"DOI":"10.13039\/501100013349","name":"Swiss Lung Association","doi-asserted-by":"crossref","award":["2022-01"],"award-info":[{"award-number":["2022-01"]}],"id":[{"id":"10.13039\/501100013349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic sclerosis and localized scleroderma are rheumatoid fibrotic diseases characterized by altered blood vessel permeability and dysregulated angiogenesis. MAGI1 is an intracellular protein expressed at the epithelial and endothelial cell junction, regulating cell adhesion and epithelial\/endothelial integrity. Endothelial cell MAGI1 regulates angiogenic function and blood flow. In the present study, we investigated the role of transgenic human MAGI1 in endothelial cells in animal models of localized scleroderma and systemic sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Wild-type and human MAGI1-overexpressing endothelial cells in mice were challenged with sodium hypochlorite or bleomycin injections to induce sclerosis\/scleroderma, mimicking the human disease. Conventional methods and automated software were employed to investigate the integrity of lung and skin tissue and quantify fibrosis. In vivo permeability and in vitro angiogenic models were employed to investigate the regulation of endothelial cell function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Dermal thickening, lung tissue density, fibrotic foci development, and collagen accumulation induced by Bleomycin or sodium hypochlorite were significantly reduced in mice overexpressing human MAGI1 in endothelial cells relative to wild-type mice. Skin permeability and in vitro endothelial cell permeability were also reduced under MAGI1 overexpression. Furthermore, MAGI1 overexpression reduced the in vitro proangiogenic effects of VEGF-A, providing a putative mechanism of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicate that endothelial cells expressing transgenic human MAGI1 attenuate tissue permeability and fibrotic responses in models of bleomycin- and sodium hypochlorite-induced scleroderma\/sclerosis. MAGI1 overexpression blocks VEGF-A-induced permeability and angiogenesis in endothelial cells. Therefore, restoring endothelial cells could potentially alleviate VEGF-A-driven diseases such as localized scleroderma and systemic sclerosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-026-03777-y","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:24:28Z","timestamp":1773235468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human MAGI1 expression in endothelial cells protects from the development of localized and systemic scleroderma in mice"],"prefix":"10.1186","volume":"28","author":[{"given":"Oriana","family":"Coquoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Schlunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilayda","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie Hoffmann","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Serdjebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Stalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"Pt 2","key":"3777_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/3-540-36028-x_3","volume":"176","author":"G Garcia-Cardena","year":"2006","unstructured":"Garcia-Cardena G, Gimbrone MA Jr. Biomechanical modulation of endothelial phenotype: implications for health and disease. Handb Exp Pharmacol. 2006;176(Pt 2):79\u201395. https:\/\/doi.org\/10.1007\/3-540-36028-x_3. 79\u201395.","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"3777_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JC Pober","year":"2007","unstructured":"Pober JC, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7(10):803\u201315. https:\/\/doi.org\/10.1038\/nri2171.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"3777_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, De Keyser F, Distler O, Gutermuth J, Smith V. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review. Autoimmun Rev. 2017;16(8):774\u201386. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.024.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3777_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/1346-8138.14153","volume":"45","author":"Y Asano","year":"2018","unstructured":"Asano Y. Systemic sclerosis. J Dermatol. 2018;45(2):128\u201338. https:\/\/doi.org\/10.1111\/1346-8138.14153.","journal-title":"J Dermatol"},{"issue":"10103","key":"3777_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9.","journal-title":"Lancet"},{"issue":"9","key":"3777_CR6","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Ch\u00e9reau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol. 2009;182(9):5855\u201364. https:\/\/doi.org\/10.4049\/jimmunol.0803705.","journal-title":"J Immunol"},{"issue":"8","key":"3777_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, De Keyser F, Distler O, Gutermuth J, Smith V. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review. Autoimmun Rev. 2017;16(8):774\u201386. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.024.","journal-title":"Autoimmun Rev"},{"key":"3777_CR8","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.redox.2019.101122","volume":"25","author":"L Doridot","year":"2019","unstructured":"Doridot L, Jeljeli M, Ch\u00eane C, Batteux F. Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol. 2019;25:101122. https:\/\/doi.org\/10.1016\/j.redox.2019.101122.","journal-title":"Redox Biol"},{"issue":"11","key":"3777_CR9","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::aid-art445>3.0.co;2-1","volume":"44","author":"P Sambo","year":"2001","unstructured":"Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653\u201364. https:\/\/doi.org\/10.1002\/1529-0131(200111)44:11%3C;2653::aid-art445%3E;3.0.co;2-1.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3777_CR10","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48(8):2246\u201355. https:\/\/doi.org\/10.1002\/art.11073.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3777_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","volume":"90","author":"MF Careta","year":"2015","unstructured":"Careta MF, Romiti R Localized scleroderma: clinical spectrum and therapeutic update. Bras Dermatol. 2015;90(1):62\u201373. . https:\/\/doi.org\/10.1590\/abd1806-4841.20152890.","journal-title":"Bras Dermatol"},{"issue":"2","key":"3777_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4078\/jrd.2024.0129","volume":"32","author":"HH Son","year":"2024","unstructured":"Son HH, Moon SJ. Pathogenesis of systemic sclerosis: an integrative review of recent advances. J Rheum Dis. 2024;32(2):89\u2013104. https:\/\/doi.org\/10.4078\/jrd.2024.0129.","journal-title":"J Rheum Dis"},{"key":"3777_CR13","doi-asserted-by":"publisher","unstructured":"Bruni C, Frech T, Manetti M, Rossi FW, Furst DE, De Paulis A, Rivellese F, Guiducci S, Matucci-Cerinic M, Bellando-Randone SV. Leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? Front Immunol. 2018:92045. https:\/\/doi.org\/10.3389\/fimmu.2018.02045.","DOI":"10.3389\/fimmu.2018.02045"},{"issue":"6","key":"3777_CR14","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/cells10061494","volume":"10","author":"J W\u00f6rthm\u00fcller","year":"2021","unstructured":"W\u00f6rthm\u00fcller J, R\u00fcegg C. MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions. Cells. 2021;10(6):1494. https:\/\/doi.org\/10.3390\/cells10061494.","journal-title":"Cells"},{"issue":"3","key":"3777_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1006\/bbrc.2000.2471","volume":"270","author":"IY Dobrosotskaya","year":"2000","unstructured":"Dobrosotskaya IY, James GL. MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. Biochem Biophys Res Commun. 2000;270(3):903\u20139. https:\/\/doi.org\/10.1006\/bbrc.2000.2471.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3777_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2443.2010.01387.x","volume":"15","author":"R Kimura","year":"2010","unstructured":"Kimura R, Ishida T, Kuriyama M, Hirata K, Hayashi Y. Interaction of endothelial cell-selective adhesion molecule and MAGI-1 promotes mature cell-cell adhesion via activation of RhoA. Genes Cells. 2010;15(4):385\u201396. https:\/\/doi.org\/10.1111\/j.1365-2443.2010.01387.x.","journal-title":"Genes Cells"},{"issue":"5","key":"3777_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/cells8050388","volume":"8","author":"K Ghimire","year":"2019","unstructured":"Ghimire K, Zaric J, Alday-Parejo B, Seebach J, Bousquenaud M, Stalin J, Bieler G, Schnittler H-J, R\u00fcegg C. MAGI1 Mediates eNOS Activation and NO Production in Endothelial Cells in Response to Fluid Shear Stress. Cells. 2019;8(5):388. https:\/\/doi.org\/10.3390\/cells8050388.","journal-title":"Cells"},{"issue":"1","key":"3777_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/19336918.2021.1911472","volume":"15","author":"B Alday-Parejo","year":"2021","unstructured":"Alday-Parejo B, Ghimire K, Coquoz O, Albisetti GW, Tam\u00f2 L, Zaric J, Stalin J, R\u00fcegg C. MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis. Cell Adh Migr. 2021;15(1):126\u201339. https:\/\/doi.org\/10.1080\/19336918.2021.1911472.","journal-title":"Cell Adh Migr"},{"key":"3777_CR19","doi-asserted-by":"publisher","unstructured":"Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc. 2018;2018(6). https:\/\/doi.org\/10.1101\/pdb.prot095505.","DOI":"10.1101\/pdb.prot095505"},{"issue":"23","key":"3777_CR20","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/ijms222312827","volume":"22","author":"M Ghasemi","year":"2021","unstructured":"Ghasemi M, Turnbull T, Sebastian S, Kempson I, The MTT, Assay. Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int J Mol Sci. 2021;22(23):12827. https:\/\/doi.org\/10.3390\/ijms222312827.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3777_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-018-9613-x","volume":"21","author":"P Nowak-Sliwinska","year":"2018","unstructured":"Nowak-Sliwinska P, Alitalo K, Allen E, et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018;21(3):425\u2013532. https:\/\/doi.org\/10.1007\/s10456-018-9613-x.","journal-title":"Angiogenesis"},{"issue":"10","key":"3777_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev. 2011;10(10):590\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2011.04.019.","journal-title":"Autoimmun Rev"},{"issue":"18","key":"3777_CR23","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.3390\/ijms241814385","volume":"24","author":"E Patnaik","year":"2023","unstructured":"Patnaik E, Lyons M, Tran K, Pattanaik D. Endothelial Dysfunction in Systemic Sclerosis. Int J Mol Sci. 2023;24(18):14385. https:\/\/doi.org\/10.3390\/ijms241814385.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3777_CR24","first-page":"3251","volume":"34","author":"X Feng","year":"2014","unstructured":"Feng X, Jia S, Martin TA, Jiang WG. Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein. Anticancer Res. 2014;34(7):3251\u20136.","journal-title":"Anticancer Res"},{"issue":"3 Pt 1","key":"3777_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1165\/rcmb.2003-0029OC","volume":"29","author":"MP Chung","year":"2003","unstructured":"Chung MP, Monick MM, Hamzeh NY, Butler NS, Powers LS, Hunninghake GW. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol. 2003;29(3 Pt 1):375\u201380. https:\/\/doi.org\/10.1165\/rcmb.2003-0029OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3777_CR26","doi-asserted-by":"publisher","first-page":"e0170561","DOI":"10.1371\/journal.pone.0170561","volume":"12","author":"JC Gilhodes","year":"2017","unstructured":"Gilhodes JC, Jul\u00e9 Y, Kreuz S, Stierstorfer B, Stiller D, Wollin L. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis. PLoS ONE. 2017;12(1):e0170561. https:\/\/doi.org\/10.1371\/journal.pone.0170561.","journal-title":"PLoS ONE"},{"issue":"18","key":"3777_CR27","doi-asserted-by":"publisher","first-page":"e172058","DOI":"10.1172\/JCI172058","volume":"133","author":"J May","year":"2023","unstructured":"May J, Mitchell JA, Jenkins RG. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. J Clin Invest. 2023;133(18):e172058. https:\/\/doi.org\/10.1172\/JCI172058.","journal-title":"J Clin Invest"},{"issue":"1","key":"3777_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/BOR.0000000000000963","volume":"36","author":"E Romano","year":"2023","unstructured":"Romano E, Rosa I, Fioretto BS, Manetti M. The contribution of endothelial cells to tissue fibrosis. Curr Opin Rheumatol. 2023;36(1):52\u201360. https:\/\/doi.org\/10.1097\/BOR.0000000000000963.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"3777_CR29","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.3390\/ijms24108749","volume":"24","author":"W Zhao","year":"2023","unstructured":"Zhao W, Wang L, Wang Y, Yuan H, Zhao M, Lian H, Ma S, Xu K, Li Z, Yu G. Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis. Int J Mol Sci. 2023;24(10):8749. https:\/\/doi.org\/10.3390\/ijms24108749.","journal-title":"Int J Mol Sci"},{"key":"3777_CR30","doi-asserted-by":"publisher","first-page":"177472","DOI":"10.1016\/j.ejphar.2025.177472","volume":"997","author":"X Zhang","year":"2025","unstructured":"Zhang X, Sha Y, Wu Y, Guan H, Yang X, Wang W, Zhang W, Liu Y, Zhu L, Li Q. Targeting endothelial cells: A novel strategy for pulmonary fibrosis treatment. Eur J Pharmacol. 2025;997:177472. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177472.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3777_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1573397114666180809121005","volume":"15","author":"VA Flower","year":"2019","unstructured":"Flower VA, Barratt SL, Ward S, Pauling JD. The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis. Curr Rheumatol Rev. 2019;15(2):99\u2013109. https:\/\/doi.org\/10.2174\/1573397114666180809121005.","journal-title":"Curr Rheumatol Rev"},{"issue":"7\u20138","key":"3777_CR32","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s10495-025-02115-y","volume":"30","author":"X Huang","year":"2025","unstructured":"Huang X, Liu Y, Fu H, Rong X, Zhao Y. Silencing IFIT3 suppresses the EGFR\/VEGF pathway and modulates SOCS1 to attenuate skin fibrosis in systemic sclerosis. Apoptosis. 2025;30(7\u20138):1852\u201374. https:\/\/doi.org\/10.1007\/s10495-025-02115-y.","journal-title":"Apoptosis"},{"issue":"3","key":"3777_CR33","doi-asserted-by":"publisher","first-page":"e0263369","DOI":"10.1371\/journal.pone.0263369","volume":"17","author":"J Mao","year":"2022","unstructured":"Mao J, Liu J, Zhou M, Wang G, Xiong X, Deng Y. Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1alpha\/VEGF signaling in systemic sclerosis. PLoS ONE. 2022;17(3):e0263369. https:\/\/doi.org\/10.1371\/journal.pone.0263369.","journal-title":"PLoS ONE"},{"key":"3777_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","volume":"2","author":"JA Nagy","year":"2007","unstructured":"Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007;2:251\u201375. https:\/\/doi.org\/10.1146\/annurev.pathol.2.010506.134925.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"3777_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000071783","volume":"207","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology. 2003;207(2):141\u20137. https:\/\/doi.org\/10.1159\/000071783.","journal-title":"Dermatology"},{"key":"3777_CR36","doi-asserted-by":"publisher","unstructured":"Gasparini G, Cozzani E, Parodi A. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis. Cytokine 2020;125:154799. https:\/\/doi.org\/10.1016\/j.cyto.2019.154799.","DOI":"10.1016\/j.cyto.2019.154799"},{"issue":"3","key":"3777_CR37","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, Sota J, Dinarello CA. Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021;20(3):102763. https:\/\/doi.org\/10.1016\/j.autrev.2021.102763.","journal-title":"Autoimmun Rev"},{"issue":"21","key":"3777_CR38","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.3390\/jcm11216375","volume":"11","author":"P Szczepanik-Ku\u0142ak","year":"2022","unstructured":"Szczepanik-Ku\u0142ak P, Michalska-Jakubus M, Kowal M, Krasowska D. Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea. J Clin Med. 2022;11(21):6375. https:\/\/doi.org\/10.3390\/jcm11216375.","journal-title":"J Clin Med"},{"issue":"10","key":"3777_CR39","first-page":"1946","volume":"31","author":"Y Kawaguchi","year":"2004","unstructured":"Kawaguchi Y, McCarthy SA, Watkins SC, Wright TM. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts. J Rheumatol. 2004;31(10):1946\u201354.","journal-title":"J Rheumatol"},{"issue":"1","key":"3777_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/cei.13599","volume":"205","author":"P Di Benedetto","year":"2021","unstructured":"Di Benedetto P, Ruscitti P, Berardicurti O, Vomero M, Navarini L, Dolo V, Cipriani P, Giacomelli R. Endothelial-to-mesenchymal transition in systemic sclerosis. Clin Exp Immunol. 2021;205(1):12\u201327. https:\/\/doi.org\/10.1111\/cei.13599.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"3777_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/biomedicines13071771","volume":"13","author":"V Zaccone","year":"2025","unstructured":"Zaccone V, Falsetti L, Contegiacomo S, Cataldi S, Benfaremo D, Moroncini G. Systemic Sclerosis: A Key Model of Endothelial Dysfunction. Biomedicines. 2025;13(7):1771. https:\/\/doi.org\/10.3390\/biomedicines13071771.","journal-title":"Biomedicines"},{"issue":"1","key":"3777_CR42","doi-asserted-by":"publisher","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","volume":"3","author":"JN Fleming","year":"2008","unstructured":"Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DF, Schwartz SM. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE. 2008;3(1):e1452. https:\/\/doi.org\/10.1371\/journal.pone.0001452.","journal-title":"PLoS ONE"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03777-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:56:28Z","timestamp":1781639788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03777-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols were revised and approved by the Animal Care Committee of Canton de Fribourg and the Welfare Animal Officer of the University of Fribourg (authorization numbers 2020_18_FR and 2023-27-FR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}